RU2003121358A - METHOD OF INFLUENCE ON THE OUTLET OF WATERFUL MOISTURE IN PRIMARY OPEN-ANGLE ANGLE GLAUCOM - Google Patents

METHOD OF INFLUENCE ON THE OUTLET OF WATERFUL MOISTURE IN PRIMARY OPEN-ANGLE ANGLE GLAUCOM Download PDF

Info

Publication number
RU2003121358A
RU2003121358A RU2003121358/15A RU2003121358A RU2003121358A RU 2003121358 A RU2003121358 A RU 2003121358A RU 2003121358/15 A RU2003121358/15 A RU 2003121358/15A RU 2003121358 A RU2003121358 A RU 2003121358A RU 2003121358 A RU2003121358 A RU 2003121358A
Authority
RU
Russia
Prior art keywords
angle
glaucom
waterful
moisture
influence
Prior art date
Application number
RU2003121358/15A
Other languages
Russian (ru)
Other versions
RU2243749C1 (en
Inventor
Валентина Николаевна Ермакова (RU)
Валентина Николаевна Ермакова
Арон Янкелевич Бунин (RU)
Арон Янкелевич Бунин
Марк Аркадьевич Бабижаев (RU)
Марк Аркадьевич Бабижаев
Original Assignee
Московский НИИ глазных болезней им. Гельмгольца (RU)
Московский НИИ глазных болезней им. Гельмгольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский НИИ глазных болезней им. Гельмгольца (RU), Московский НИИ глазных болезней им. Гельмгольца filed Critical Московский НИИ глазных болезней им. Гельмгольца (RU)
Priority to RU2003121358/15A priority Critical patent/RU2243749C1/en
Application granted granted Critical
Publication of RU2243749C1 publication Critical patent/RU2243749C1/en
Publication of RU2003121358A publication Critical patent/RU2003121358A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ воздействия на отток водянистой влаги больных первичной открытоугольной глаукомой, отличающийся тем, что сначала вводят путем инстилляций гипотензивное средство, а через 20-30 минут - глазные капли эмоксипина два раза в день, в течение 4-8 недель; через 2-3 месяца курс лечения повторяют.A method of influencing the outflow of aqueous humor of patients with primary open-angle glaucoma, characterized in that the hypotensive agent is first administered by instillation, and after 20-30 minutes - eye drops of emoxipin twice a day, for 4-8 weeks; after 2-3 months, the treatment is repeated.
RU2003121358/15A 2003-07-15 2003-07-15 Method for influencing aqueous humor discharge in the cases of primary open angle glaucoma RU2243749C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003121358/15A RU2243749C1 (en) 2003-07-15 2003-07-15 Method for influencing aqueous humor discharge in the cases of primary open angle glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003121358/15A RU2243749C1 (en) 2003-07-15 2003-07-15 Method for influencing aqueous humor discharge in the cases of primary open angle glaucoma

Publications (2)

Publication Number Publication Date
RU2243749C1 RU2243749C1 (en) 2005-01-10
RU2003121358A true RU2003121358A (en) 2005-02-10

Family

ID=34881647

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003121358/15A RU2243749C1 (en) 2003-07-15 2003-07-15 Method for influencing aqueous humor discharge in the cases of primary open angle glaucoma

Country Status (1)

Country Link
RU (1) RU2243749C1 (en)

Also Published As

Publication number Publication date
RU2243749C1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
NO2017047I1 (en) Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, including citrate salt
BRPI0418245A (en) Nitroxy Prostaglandin Derivatives
DK0561073T3 (en) Treatment of eye hypertension
ATE420624T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
RU2000122435A (en) INDOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
ES2185153T3 (en) USE OF MEFLOQUINA (+) FOR THE TREATMENT OF MALARIA.
WO2003094905A8 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
RU2003121358A (en) METHOD OF INFLUENCE ON THE OUTLET OF WATERFUL MOISTURE IN PRIMARY OPEN-ANGLE ANGLE GLAUCOM
HUP0300863A2 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide, process for producing it and pharmaceutical composition containing it
SE9900177D0 (en) our Means
TR200200224T2 (en) Composition for the prevention and treatment of kidney disorders and diseases
NO975790D0 (en) Use of allylamine derivatives, such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection-associated diseases
ATE247963T1 (en) DRUG FOR TREATING GLAUCOMA AND ISCHEMIC RETINOPATHY
MXPA02003033A (en) Method of preventing retinopathy of prematurity in a neonate.
ATE290374T1 (en) IGA PRODUCTION INHIBITORS
RU2000104107A (en) Method for the surgical treatment of glaucoma
RU2004105675A (en) METHOD FOR COMPREHENSIVE TREATMENT OF CORNERAL ULCERS
RU2002115487A (en) METHOD FOR TREATING A RETRIDGING CYLIOCHORIOIDAL EXTRACTION AFTER ANTIGLAUCOMATOUS OPERATION
RU2001124638A (en) Method for the surgical treatment of glaucoma
RU2002109449A (en) Method for surgical treatment of open angle glaucoma
RU2004106376A (en) METHOD FOR TREATING CHORIORETHINITIS
RU2004109786A (en) METHOD FOR TREATING DISORDERS OF MNESTIC FUNCTIONS
DE60210804D1 (en) USE OF PROPIONYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF LA PEYRONIE'S DISEASE
TH99615A (en) Prostaglandin derivatives

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20050716